Loading...
Loading...
Application UK00801123545 · Dead
| Application Number | UK00801123545 |
| Status | Dead |
| Owner | H. Lundbeck A/S |
| Filed | 2012-03-26 |
| Registered | 2013-06-18 |
| Renewal Due | 2022-03-26 |
| Type | Individual |
| Feature | Word |
EZACTRIS has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes.
'EZACTRIS' is a dead trademark on the UK IPO register, owned by H. Lundbeck A/S. The application (UK00801123545) was filed on 26 March 2012 and registered on 18 June 2013. The registration is set to expire on 26 March 2022.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
UK trademark UK00801123545 for the mark 'EZACTRIS' in Class 5 is recorded on the UK IPO register as owned by H. Lundbeck A/S. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00801123545 for the mark 'EZACTRIS' as dead.
UK trademark UK00801123545 for the mark 'EZACTRIS' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; ph…
UK trademark UK00801123545 for the mark 'EZACTRIS' was filed at the UK IPO on 26 March 2012 and registered on 18 June 2013.
UK trademark UK00801123545 for the mark 'EZACTRIS' is currently recorded as valid until 26 March 2022, at which point it will need to be renewed with the UK IPO to remain in force.
Trademarks matching "EZACTRIS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| EZACTRISSame applicant | 79115742 | 402 | 2012-03-26 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| EZACTRISSame applicant | 1508505 | lapsed | 2012-08-16 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.